Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Urcelay

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Pharmacogenomics|August 18, 2010
IFN-beta pharmacogenomics in multiple sclerosisKoen Vandenbroeck, Elena Urcelay, Manuel Comabella
Frontiers in Immunology|July 1, 2025
Osteopontin as a diagnostic and NTZ-response biomarker of multiple sclerosis: a systematic review and meta-analysisAdela González-Jiménez, Elena Urcelay, Laura Espino-Paisán
Revista Espanola De Enfermedades Digestivas|April 28, 2018
HLA-DQ distribution and risk assessment of celiac disease in a Spanish centerEva Martínez-Ojinaga, Manuel Molina, Isabel Polanco, et al.
Current Medicinal Chemistry|February 28, 2018
New Life to an Old Treatment: Pegylated Interferon Beta 1a in the Management of Multiple SclerosisMiguel Angel Ortiz, Laura Espino-Paisan, Concepcion Nunez, et al.
BMC Gastroenterology|June 15, 2019
Influence of HLA on clinical and analytical features of pediatric celiac diseaseEva Martínez-Ojinaga, Marta Fernández-Prieto, Manuel Molina, et al.
Medicina Clinica|December 17, 2008
[Influence of mutations of proteinase-activated receptors F2R/PAR1 and F2RL1/PAR2 on inflammatory bowel disease]M Carmen Martín, Javier Oliver, Juan Luis Mendoza, et al.
The American Journal of Gastroenterology|April 2, 2009
Suggested association of NOS2A polymorphism in idiopathic achalasia: no evidence in a large case-control studyAna González Vigo, Alfonso Martínez, Emilio G de la Concha, et al.
Human Immunology|August 16, 2008
Role of IL-10 promoter polymorphisms in the development of severe aorto-iliac occlusive diseaseEstrella Blanco, Guillermo Moñux, Ana Mas, et al.
Clinical Rheumatology|December 28, 2018
Functional implications of single nucleotide polymorphisms rs662 and rs854860 on the antioxidative activity of paraoxonase1 (PON1) in patients with rheumatoid arthritisArkaitz Mucientes, Benjamín Fernández-Gutiérrez, Eva Herranz, et al.
Journal of Neuroimmunology|October 31, 2007
TLR4 haplotypes in multiple sclerosis: a case-control study in the Spanish populationElena Urcelay, Fiona Blanco-Kelly, Virginia de Las Heras, et al.
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Pharmacogenomics|August 18, 2010
IFN-beta pharmacogenomics in multiple sclerosisKoen Vandenbroeck, Elena Urcelay, Manuel Comabella
Frontiers in Immunology|July 1, 2025
Osteopontin as a diagnostic and NTZ-response biomarker of multiple sclerosis: a systematic review and meta-analysisAdela González-Jiménez, Elena Urcelay, Laura Espino-Paisán
Revista Espanola De Enfermedades Digestivas|April 28, 2018
HLA-DQ distribution and risk assessment of celiac disease in a Spanish centerEva Martínez-Ojinaga, Manuel Molina, Isabel Polanco, et al.
Current Medicinal Chemistry|February 28, 2018
New Life to an Old Treatment: Pegylated Interferon Beta 1a in the Management of Multiple SclerosisMiguel Angel Ortiz, Laura Espino-Paisan, Concepcion Nunez, et al.
BMC Gastroenterology|June 15, 2019
Influence of HLA on clinical and analytical features of pediatric celiac diseaseEva Martínez-Ojinaga, Marta Fernández-Prieto, Manuel Molina, et al.
Medicina Clinica|December 17, 2008
[Influence of mutations of proteinase-activated receptors F2R/PAR1 and F2RL1/PAR2 on inflammatory bowel disease]M Carmen Martín, Javier Oliver, Juan Luis Mendoza, et al.
The American Journal of Gastroenterology|April 2, 2009
Suggested association of NOS2A polymorphism in idiopathic achalasia: no evidence in a large case-control studyAna González Vigo, Alfonso Martínez, Emilio G de la Concha, et al.
Human Immunology|August 16, 2008
Role of IL-10 promoter polymorphisms in the development of severe aorto-iliac occlusive diseaseEstrella Blanco, Guillermo Moñux, Ana Mas, et al.
Clinical Rheumatology|December 28, 2018
Functional implications of single nucleotide polymorphisms rs662 and rs854860 on the antioxidative activity of paraoxonase1 (PON1) in patients with rheumatoid arthritisArkaitz Mucientes, Benjamín Fernández-Gutiérrez, Eva Herranz, et al.
Journal of Neuroimmunology|October 31, 2007
TLR4 haplotypes in multiple sclerosis: a case-control study in the Spanish populationElena Urcelay, Fiona Blanco-Kelly, Virginia de Las Heras, et al.
Pageof 15